Strengthening AMR surveillance in PNG with UK support
Offering COVID-19 booster vaccinations alongside influenza vaccinations could reduce hospitalisations and deaths
Driving innovation and expanding our global impact
Australia faces rising threats from synthetic opioids
Research Reports + Policy Briefs
IMPACT Magazine
Events
Research Articles
How Science Matters Podcast
Study at Burnet
"Quick, simple, and friendly": Understanding the acceptability and accessibility...
Thou doth protest too much: How the minimum unit price affected retailers' reven...
Does parental cohort increase the likelihood of underage alcohol consumption in...
A systematic review of adolescent alcohol-related harm trends in high-income cou...
Partner with us
Burnext accelerator program
Australia
Papua New Guinea
Myanmar
People of Burnet
Leadership
Burnet Partners
Board Members
Appeals
Monthly Giving
Trusts + Foundations
Corporate Supporters
Giving in Wills + Bequests
Endowment Giving
About Us
Careers
History
Annual + Financial Reports
Explore our research reports and policy briefs, designed to explain key findings of our work clearly and provide recommendations for government, community organisations and policymakers alike.
For peer reviewed publications, see: Research Articles
Rapid EC: Point-of-care testing for hepatitis C at needle and syringe programs is feasible and accep...
Young male prisoners with a history of injecting drug use are among the most disadvantaged and vulne...
Universal availability of hepatitis C treatment is a critical but insufficient step towards eliminat...
Implementation of a remote consultation pathway facilitates interaction between general practitioner...
Targeted interventions are needed to increase hepatitis C treatment uptake in non- metropolitan area...
Routine testing and prompt treatment uptake can significantly reduce hepatitis C prevalence among HI...
The Salvation Army commissioned the Burnet Institute to gather data on its 24-hour needle and syring...
Universal access to hepatitis C medication alone is insufficient to eliminate hepatitis C as a publi...
A Burnet Institute survey undertaken in 2016 showed that although many general practitioners are int...
Hepatitis C incidence appears to be decreasing, but in a cohort of people who inject drugs in Melbou...
People who inject drugs experience high levels of psychological distress and recent assault, intenti...
A systematic review conducted in 2015 demonstrated that – compared to tertiary- based hepatitis C ca...
Reaching the WHO hepatitis C elimination targets in Australia is cost-effective and can be achieved ...
Treating people who inject drugs for hepatitis C with new therapies is cost-effective and could prev...
Even a partially effective hepatitis C vaccine could effectively complement existing treatments to r...
China is confronted with a significant challenge in managing a substantial population afflicted with...
This project was undertaken to provide a detailed understanding of the interface between the price o...
Significant and ongoing Burnet Institute research has provided important insights into the social ne...
Background: Understanding of substitution patterns in drug using careers is limited. Between 2009 an...
Gender and genetics could identify people who are more likely to eliminate hepatitis C after reinfec...
